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Table 2
Parameter Group 1 (n = 110) Group 2 (n = 110) p
24-hour SBP (mmHg) 120.1  9.1 117.8  6.0 0.02
24-hour DBP (mmHg) 76.0  7.2 74.0  6.5 0.03
24-hour MABP (mmHg) 90.7  7.8 87.9  5.9 <0.01
24-hour HR (bpm) 75.8  8.1 76.2  6.3 0.72
Daytime SBP (mmHg) 124.3  9.3 121.9  6.7 0.03
Daytime DBP (mmHg) 79.3  7.5 78.1  7.5 0.24
Night-time SBP (mmHg) 113.7  9.1 109.4  6.0 <0.01
Night-time DBP (mmHg) 69.8  7.5 66.5  5.2 <0.01
D Day-Night SBP (mmHg) 9.0  4.4 10.5  4.2 0.01
D Day-Night DBP (mmHg) 11.1  5.9 14.0  6.4 <0.01
Early Morning
Average SBP (mmHg)
111.7  11.0 109.8  12.8 0.31
Early Morning
Average DBP (mmHg)
68.7  9.4 66.2  12.8 0.17
Ambulatory blood pressure monitoring results of the patients (group 1) and control subjects
(group 2).
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Hypertension accounts for number of morbidities and mortalities in Syria. We know
that each speciﬁc population has its own particulars and might have different
responses to drugs due to pharmacokinetics and pharmacodynamics. In Syria, there
are many national pharmaceutical companies which produce multiple antihypertensive
drugs.
In order to comply with Evidence Based Medicine, we studied two antihypertensive
drugs produced by these companies. Two large Post Marketing Surveillance studies
were carried out and they were the pioneer efforts in Syria. They looked at efﬁcacy,
safety and tolerability of Rennin Angiotensin Aldosterone System suppressing drugs.
The ﬁrst study VHEST (Valsartan in Hypertension, Efﬁcacy, Safety and Toler-
ability) and the second study REST (Revosyl Efﬁcacy, Safety and Tolerability)
while Revosyl is the market name for Perindopril.
These studies were done by a protocol put by an experienced hypertensive specialist
and carried out by number of physicians in different geographic locations in Syria.
These studies were open label, controlled, observational, prospective, post marketing,
non interventional clinical studies.
VHEST included 1500 essential hypertension patients (grade I, II and Isolated
systolic hypertension) with a follow up of 12 weeks. Investigators were 100 physi-
cians (Cardiologists, Endocrinologists, Neurologists, Internists and Nephrologists).
Conclusion was that Valsartan  HCTZ is efﬁcacious, well tolerated and safe. The
most reported side effects were headache& dizziness.
REST included 2250 patients with Essential Hypertension (Grade I, II& Isolated
Systolic Hypertension). Follow up was 12 weeks and 141 physicians participated. It
showed that Perindopril is efﬁcacious with an acceptable level of systolic and diastolic
blood pressure reduction and a good control and response rates. The concomitant
presences of CHF or renal disease were associated with intense reduction of DBP
while patients with concomitant cerebrovascular accidents or left ventricular hyper-
trophy showed a tendency to reduce SBP easier. The most frequently reported side
effects were cough& headache.
In conclusion, antihypertensive drugs produced by national pharmaceutical
companies are reasonable choice for treating patients with hypertension.
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Depressive disorders of an mild and medium degree of severity at cardiological
patients at present are one of actual problems of modern medicine. It became possible
in spite of the fact that last years there was a lot of the new highly effective antide-
pressants which are not possessing unlike to classical tricyclic antidepressant, the
expressed behavioural toxicity and negative inﬂuence on activity of cardiovascular
system. Besides medicamentous therapy in the literature there are reports on efﬁciency
of herbal therapy as antidepressants (Wonnemann M. And co-authors., 2000). One of
the most effective in a therapeutic practice of plants is common St. John’s wort,
(Hypericum perforatum).JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTThe purpose of research. To study comparative efﬁciency of some antidepressants
from group of selective inhibitors of recapture of the serotonin (SIRS) and an extract of
St. John’s wort, (Hypericum perforatum) in treatment of depressive disorders at arterial
hypertension (AH) patients with (AH) with the hypertensive encephalopathy (HE).
Results of research. The comparative analysis of results has shown, that in all
groups of treatment by 3 month as a whole at 86,6% of patients are reached special-
purpose values the of AH and stabilization of clinical course of HE (p<0,001), 68,3%
of patients have returned to a former level of psychosocial functioning (p<0,001).
Improvement of a psychological condition was shown in reduction of emotional
lability, anxiety, phobia, depression, sleep disturbance, improvement of mood and
efﬁciency. The retrospective analysis of results of treatment has shown, that each of
used SIRS had some features of psychotropic action.
At prescription to patients with AH with HE of 15 gr/daily an extract of St. John’s
wort, (Hypericum perforatum) if the initial score with depressive disorders on scale
Beck made 22,61,2 in the subsequent it is statistically certainly (p<0,05) has
decreased up to 13,81,1 points. In 2 months from the beginning of reception of an
extract of St. John’s wort, (Hypericum perforatum) at AH patients with psychological
disorders, decrease of depression was marked on 35% from initial. Efﬁciency of
therapy with an extract of St. John’s wort, (Hypericum perforatum) to the end of third
months of supervision has averaged 55% (p<0,05).
Conclusions: On the basis of the received results it has been proved, that at AH
patients with HE for correction of depressive disorders is necessary the differentiated
setting of antidepressants from group of selective inhibitors of recapture of serotonin.
Application of an extract of St. John’s wort, (Hypericum perforatum) in a dose of 15
gr/daily show the positive antidepressive effect, but this effect on anxiously- phobic
disorders was insufﬁciently.
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The circulating level of NT-pro BNP serves as a sensitive marker of left ventricular
hypertrophy and volume expansion. it has been demonstrated that hypervolemia, an
increase in sympathetic function may co ntribute to the occurrence of the non-dipping
phenomenon Also both higher NT-pro BNP levels and non-dipper hypertension have
been shown to predict cardiovascular events and mortality in the general pop-
ulation.Thus, the aim of this study is to determine whether an association exists
between NT-BNP and non-dipper hypertension and to evaluate the predictive value of
N-Terminal- pro brain natriuretic peptide (NT-proBNP) in non-dipping pattern in
patients with hypertensive.
Methods: We enrolled 333 consecutive hypertensive patients with no cardiovascular
disease (mean age 49.910.8 years, %50.6 men). Ambulatory blood pressure moni-
toring was performed in all patients and according to the values of ambulatory BP, the
patients were divided into two groups. Non-dipper hypertensive group (n¼177),
dipper hypertensive group (n¼155).
Results: NT-pro BNP was higher in non-dipper hypertensive group than in dipper
hypertensive group (81.5 94 pg/ml, 48.766 pg/ml, p <0.001 respectively). There
was correlation between NT-pro BNP and systolic blood pressure (especially at night),
age (r¼0.233, p<0.001, r¼0.339, p<0.001). NT-pro BNP was no correlation with
diastolic blood pressure. In logistic multivariate analysis; NT-pro BNP value was
found to be a independent predictor of non-diping pattern development (odds ratio:
1.022, 95% conﬁdence interval: 1.007-1.038, p<0.05) and In a receiver operating
characteristic (ROC) curve analysis, a BNP value of 38.5 pg/ml was identiﬁed as an
effective cut-off point for Non-dipper hypertension (area under curve¼0.663, 95%
conﬁdence interval (CI) 0.64 to 0.721, p<0.001). NT-pro BNP of > 38.5 pg/ mL
yielded a sensitivity of 61.6% and a speciﬁcity of 60% for non-dipper hypertension.
Conclusıons: These results suggest that non-dipper pattern could be identiﬁed using
the NT-pro BNP level in patients with hypertensive without clinically overt cardio-
vascular disease and renal failure in clinical practice.ERS C95
